期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2021; 31 (2)
Background: Schizophrenia is a serious mental illness affecting 0.3-0.7% of the world's population. It is a classic quantitative genetic disease and i......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2021; 31 (2)
Objective: Bipolarity index (BI) is one of the diagnostic scales that assist the diagnosis of bipolar disorder (BD), and should be analyzed comprehens......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2021; 31 (2)
This study explored the first-person lived experiences of 2 nurses and 2 doctors combating coronavirus disease 2019 (COVID-19) in Wuhan, China. The in......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2021; 31 (2)
Background: In early December 2019, during the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first detected ......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2020; 30 (2)
Background: The NIMH launched a Research Domain Criteria (RDoC) initiative, which encouraged researchers to shift from traditional categorical concept......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2020; 30 (4)
The bilateral and symmetrical Wallerian degeneration (WD) of the middle cerebella peduncles (MCPs) is rarely reported in pontine hemorrhage. We descri......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2020; 30 (4)
Background: Supportive family environments can improve the prognosis of patients with schizophrenia by enhancing treatment compliance, social cognitio......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2020; 30 (4)
Background: Repetitive transcranial magnetic stimulation (rTMS) has been used as an adjunct therapy to improve the cognitive abilities of patients wit......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2020; 30 (3)
Background: Visual abnormalities are common among patients with schizophrenia and have been associated with retinal thickness impairment (RTI). A reli......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2020; 30 (3)
Background: Maintenance treatment with electroconvulsive therapy (ECT) and adjunct antipsychotics can alleviate symptoms of treatment-resistant schizo......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2020; 30 (3)
Background: As antipsychotic agents are the primary treatment for schizophrenia, treatment compliance plays an important role in the prognosis of pati......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2019; 29 (4)
Background: The present study aimed to systematically evaluate three prolactin-sparing antipsychotics for treating schizophrenia. Methods: We performe......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2019; 29 (4)
BACKGROUND: To investigate the effects of adjunct ketamine treatment on depressive symptoms and brain activity in chronic treatment-resistant schizoph......
期刊： PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2022; 32 (3)
Background: It has been shown that autoimmune diseases are associated with psychiatric disorders in epidemiological studies. The acute psychiatric dis......
